Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1161 of 1,261
  1. US 6686454

    Antibodies to specific regions of cyclosporine related compounds

    Isotechnika, Inc. Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  2. US 6686362

    Indolinone derivatives

    Theravance, Inc. Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  3. US 6685933

    Interferon &agr; hybrids

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  4. US 6686338

    Enzyme inhibitors for metabolic redirection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  5. US 6685945

    Cloned Leptospira outer membrane protein

    The Regents of the University of California Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  6. US 6686334

    Use of inhibitors of protein kinase C epsilon to treat pain

    The Regents of the University of California Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  7. US 6686190

    Methods for enhancing the production of viral vaccines in cell culture

    The Regents of the University of California Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  8. US 6686383

    Prophylactic or therapeutic drug for renal diseases

    Takeda Chemical Industries Ltd. Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  9. US 6686333

    Inhibition of HIV replication using soluble Tat peptide analogs

    The United States of America as represented by the Department of Health and Human Resources Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  10. US 6685944

    Modified HCV peptide vaccines

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  11. US 6685941

    Methods of treating autoimmune disease via CTLA-4Ig

    United States of America as represented by the Secretary of the Air Force Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  12. US 6685626

    Compositions, devices, methods, and kits for induction of adhesions

    Regeneration Technologies, Inc. Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  13. US 6686445

    Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  14. US 6685967

    Methods and compositions for pulmonary delivery of insulin

    Nektar Therapeutics Β· Granted Feb 3, 2004 Β· Expires Jan 29, 2024

    expired
  15. US 6683069

    Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  16. US 6683058

    Methods for therapy of neurodegenerative disease of the brain

    The Regents of the University of California Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  17. US 6682917

    Protein having a ribonucleotide Reductase activity and a DNA thereof

    Takeda Chemical Industries Ltd. Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  18. US 6683160

    Antibodies specific for Fkhsf gene products

    Darwin Discovery Limited Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  19. US 6683096

    Indolylpiperidine derivatives as antihistaminic and antiallergic agents

    Almirall Prodesfarma S.A. Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  20. US 6683171

    Identification of the gene causing the mouse scurfy phenotype and its human ortholog

    Darwin Discovery Limited Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  21. US 6683059

    Mini-E1A gene and gene products

    The Board of Regents of the University of Texas System Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  22. US 6683047

    Method of inhibiting transcription utilizing nuclear receptors

    The Regents of the University of California Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  23. US 6682906

    Cloned glutamic acid decarboxylase

    The Regents of the University of California Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  24. US 6682890

    Methods of diagnosing and determining prognosis of colorectal cancer

    Protein Design Labs, Inc. Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.